Evidence map›Paper›PMID 27562039›Full record

ArticleScientific reports2016

The Cytomegalovirus protein pUL37×1 targets mitochondria to mediate neuroprotection.

Chien Tai Hong, Kai-Yin Chau, Anthony H V Schapira

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Host Mitochondrial Requirements of Cytomegalovirus Replication.Current clinical microbiology reports · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Chien Tai HongDepartment of Clinical Neuroscience, UCL Institute of Neurology, University College London, UK.
Kai-Yin ChauDepartment of Clinical Neuroscience, UCL Institute of Neurology, University College London, UK.
Anthony H V SchapiraDepartment of Clinical Neuroscience, UCL Institute of Neurology, University College London, UK.
University College London · GBTaipei Medical University · TW

Funding

Medical Research Council MR/M006646/1
6 · The paper itself

Abstract

There is substantial evidence that mitochondrial dysfunction plays a significant role in the pathogenesis of Parkinson disease (PD). This contribution probably encompasses defects of oxidative phosphorylation, mitochondrial turnover (mitophagy), mitochondrial derived oxidative stress, and apoptotic signalling. Human cytomegalovirus immediate-early protein pUL37 × 1 induces Bax mitochondrial translocation and inactivation to prevent apoptosis. Over-expressing pUL37 × 1 in neuronal cells protects against staurosporin and 6-hydroxydopamine induced apoptosis and cell death. Protection is not enhanced by bax silencing in pUL37 × 1 over-expressing cells, suggesting a bax-dependent mechanism of action. pUL37 × 1 increases glycolysis and induces mitochondrial hyperpolarization, a bax independent anti-apoptotic action. pUL37 × 1 increases glycolysis through activation of phosphofructokinase by a calcium-dependent pathway. The dual anti-apoptotic mechanism of pUL37 × 1 may be considered a novel neuroprotective strategy in diseases where mitochondrial dysfunction and apoptotic pathways are involved.

Indexed as

Animalsbcl-2-Associated X ProteinCell LineCytomegalovirusExonsGlycolysisHumansImmediate-Early ProteinsMitochondriaMitophagyNeuroprotective AgentsOxidative PhosphorylationOxidative StressOxidopamineProtein TransportRatsBAX protein, humanbcl-2-Associated X ProteinImmediate-Early ProteinsNeuroprotective AgentsOxidopamineStaurosporineUL37 protein, Human herpesvirus 5

Identifiers

PMID27562039
PMCPMC4999870
OpenAlexW2508810285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.